Related Experiment Video
Updated: Mar 26, 2026

Chemo-enzymatic Synthesis of N-glycans for Array Development and HIV Antibody Profiling
Published on: February 5, 2018
O-GlcNAc transferase inhibitors: current tools and future challenges.
Riccardo Trapannone1, Karim Rafie1, Daan M F van Aalten2
1Medical Research Council Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
O-GlcNAcylation, a key protein modification, is regulated by OGT and OGA. This review details OGT inhibitors, crucial for studying O-GlcNAc roles in health and disease.
Area of Science:
- Biochemistry
- Molecular Biology
- Cellular Biology
Background:
- O-linked N-acetylglucosamine (O-GlcNAc) is a dynamic post-translational modification found on hundreds of nucleocytoplasmic proteins.
- O-GlcNAcylation impacts numerous biological functions and is implicated in various human diseases.
- The enzymes O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA) catalyze the addition and removal of O-GlcNAc, respectively.
Purpose of the Study:
- To review available chemical inhibitors of O-GlcNAc transferase (OGT).
- To discuss the necessity of OGT inhibitors for studying O-GlcNAc biology, especially given OGT knockout lethality.
- To summarize the advantages, limitations, and future challenges associated with OGT inhibitors.
Main Methods:
- Literature review of existing OGT inhibitors.
- Analysis of the utility of OGT inhibitors in biological systems.
- Discussion of challenges in developing and applying OGT inhibitors.
Main Results:
- OGT knockout studies are limited by embryonic lethality in animal models.
- Selective OGT inhibitors are essential tools for dissecting the catalytic and non-catalytic roles of OGT.
- A range of OGT inhibitors with varying potencies and specificities exist.
Conclusions:
- Targeted inhibition of OGT is critical for understanding its diverse biological roles and implications in disease.
- Further development of selective and potent OGT inhibitors is needed.
- Addressing the limitations of current OGT inhibitors will facilitate future research in O-GlcNAc biology.
More Related Videos
14:57Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Pharmacogenomics: Identification of New Drug Targets
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...